Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°áÁ÷Àå¾Ï¿¡¼­ Met ´Ü¹éÀÇ ¹ßÇö Expression of Met Protein in Colorectal Carcinoma

´ëÇѺ´¸®ÇÐȸÁö 2000³â 34±Ç 7È£ p.501 ~ 508
ÃÖ°æ¿î, ÀÌÁø¼÷, ÀÌâÈÆ, ¼³¹Ì¿µ, ¼­°­¼®,
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖ°æ¿î ( Choi Kyung-Un ) 
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

ÀÌÁø¼÷ ( Lee Jin-Sook ) 
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÀÌâÈÆ ( Lee Chang-Hun ) 
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¼³¹Ì¿µ ( Sol Mi-Young ) 
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¼­°­¼® ( Suh Kang-Suk ) 
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract


Met protein is a transmembrane 190 kD heterodimer with tyrosine kinase activity, encoded by c-Met oncogene. It serves as a high affinity receptor for hepatocyte growth factor (HGF)/scatter factor (SF), a cytokine which stimulates cell proliferation, motility, and invasion. In this study, we immunohistochemically evaluated the expression of Met/hepatocyte growth factor receptor in colorectal cancers. Met protein was expressed in 31 of 72 patients (43.1%). The staining pattern was cytoplasmic in nature, present throughout the tumor, and showed variable intensity from case to case. The relationship between the expression rate and intensity, and age and sex of patients, tumor size (p=0.645), tumor site (p=0.902) and tumor differentiation (p=0.844) was not statistically significant. The expression rate and intensity were significantly correlated with lymphovascular invasion (p=0.001), lymph node metastasis (p=0.010), depth of invasion (0.019), and stage (p=0.023). Cytoplasmic accumulation of Met protein was not associated with enhanced PCNA index of tumor cells (p=0.052). These results suggest that Met protein may play an important role in the invasion and metastasis of colorectal cancer cells.

Å°¿öµå

Colorectal;Carcinoma;Met protein;Hepatocyte growth factor;PCNA

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS